|
Most Frequent Non-fatal Serious Adverse Events |
|||
| Number |
% of total patients |
Rate/100 PYE (95% CI) |
|
|
|
|||
| QTC prolongation |
15 |
1.05 |
0.85 (0.48–1.41) |
| Suicide attempts/Other overdoses |
7 |
0.49 |
0.40 (0.16–0.82) |
| Heart Rate Anomaly |
4 |
0.28 |
0.23 (0.06–0.58) |
| Convulsion |
4 |
0.28 |
0.23 (0.06–0.58) |
| Overdose of sertindole |
4 |
0.28 |
0.23 (0.06–0.58) |
| Syncope |
3 |
0.21 |
0.17 (0.04–0.50) |
| Carcinoma/Tumour |
2 |
0.14 |
0.11 (0.01–0.41) |
| Other serious adverse event |
48 |
3.35 |
2.73 (2.01–3.62) |
|
|
|||
| Total |
87 |
6.08 |
4.95 (3.96–6.10) |
Lançon et al. BMC Psychiatry 2008 8:57 doi:10.1186/1471-244X-8-57 |
|||